BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

NEURIM PHARMACEUTICALS — Lobbying — Receipts Report

LD-2 disclosure · Registration

NEURIM PHARMACEUTICALS

via POLSINELLI PC

2nd Quarter (Apr 1 - June 30) · 2026Posted May 5, 2026Filing document ↗LDA record ↗

Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.

Client

Name: NEURIM PHARMACEUTICALS
Description: pharmaceutical company
Location: Israel

Registrant

Firm: POLSINELLI PC
Description: Law Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
Issues relating to FDA regulations relating to pharmaceuticals.
LobbyistsMICHAEL M GABA

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.